🔎 Trials Near Me

Home › COPD › Tennessee

Pag-aaral pangklinika para sa COPD sa Tennessee

16 pag-aaral para sa COPD ang naghahanap ng mga kalahok sa mga site sa Tennessee.

Mga Lungsod sa Tennessee

Opisyal na teksto ng pag-aaral (English)

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Chattanooga
  • Research Site, Franklin
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07082738

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Chattanooga Research and Medicine- Site Number : 8400026, Chattanooga
  • Premier Research Center, Llc- Site Number : 8400146, Hendersonville
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 23, 2026 · NCT07190222

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Clinical Trials Center of Middle Tennessee, LLC, Franklin
  • Premier Research Center, LLC, Hendersonville
Nagre-recruitPhase 2/3
Edad 35 hanggang 80 · Lahat ng kasarian · Na-update Okt 22, 2026 · NCT07363694

Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators

  • The University of Tennessee Graduate School of Medicine, Knoxville
Nagre-recruitPhase 4
Edad 40 pataas · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07133880

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • Meharry Medical College- Site Number : 8400133, Nashville
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 19, 2026 · NCT07190209

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Hendersonville
  • Research Site, Knoxville
  • Research Site, Lebanon
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 9, 2026 · NCT06878261

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Knoxville
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06961214

Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation

  • GSK Investigational Site, Franklin
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06959095

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Chattanooga
  • Research Site, Franklin
  • Research Site, Tullahoma
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06283966

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  • Fort Sanders Regional Medical Center (StatCare), Knoxville
Nagre-recruit
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06035120

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • Vanderbilt University Medical Center, Nashville
Nagre-recruitPhase 2
Edad 40 pataas · Lahat ng kasarian · Na-update Set 4, 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Franklin
  • Research Site, Johnson City
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06883305

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Knoxville
Nagre-recruitPhase 3
Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Hul 28, 2026 · NCT07177339

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

  • Methodist LeBonheur Healthcare, Memphis
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 10, 2026 · NCT05181826

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

  • The Jackson Clinic, PA, Jackson
Nagre-recruitObservasyonal na pag-aaral
Edad 50 pataas · Lahat ng kasarian · Na-update Ago 5, 2025 · NCT06122077

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.